123 related articles for article (PubMed ID: 16439199)
1. REGgamma: a shortcut to destruction.
Zhou P
Cell; 2006 Jan; 124(2):256-7. PubMed ID: 16439199
[TBL] [Abstract][Full Text] [Related]
2. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome.
Li X; Lonard DM; Jung SY; Malovannaya A; Feng Q; Qin J; Tsai SY; Tsai MJ; O'Malley BW
Cell; 2006 Jan; 124(2):381-92. PubMed ID: 16439211
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway.
Li X; Amazit L; Long W; Lonard DM; Monaco JJ; O'Malley BW
Mol Cell; 2007 Jun; 26(6):831-42. PubMed ID: 17588518
[TBL] [Abstract][Full Text] [Related]
4. REGgamma proteasome mediates degradation of the ubiquitin ligase Smurf1.
Nie J; Wu M; Wang J; Xing G; He F; Zhang L
FEBS Lett; 2010 Jul; 584(14):3021-7. PubMed ID: 20580715
[TBL] [Abstract][Full Text] [Related]
5. Atypical regulation of SRC-3.
Garabedian MJ; Logan SK
Trends Biochem Sci; 2008 Jul; 33(7):301-4. PubMed ID: 18502645
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-dependent and -independent proteasomal degradation of hepatitis B virus X protein.
Kim JH; Sohn SY; Benedict Yen TS; Ahn BY
Biochem Biophys Res Commun; 2008 Feb; 366(4):1036-42. PubMed ID: 18155658
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin dependent and independent protein degradation in the regulation of cellular polyamines.
Kahana C
Amino Acids; 2007 Aug; 33(2):225-30. PubMed ID: 17404802
[TBL] [Abstract][Full Text] [Related]
8. Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target.
Bett JS; Goellner GM; Woodman B; Pratt G; Rechsteiner M; Bates GP
Hum Mol Genet; 2006 Jan; 15(1):33-44. PubMed ID: 16311253
[TBL] [Abstract][Full Text] [Related]
9. Proteasome and transcription: a destroyer goes into construction.
Hegde AN; Upadhya SC
Bioessays; 2006 Mar; 28(3):235-9. PubMed ID: 16479576
[TBL] [Abstract][Full Text] [Related]
10. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
[TBL] [Abstract][Full Text] [Related]
11. Staying the distance: avoiding the proteasomal trap.
Downes M; Evans RM
Cancer Cell; 2008 Mar; 13(3):184-5. PubMed ID: 18328421
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a REG/PA28 proteasome activator homolog in Dictyostelium discoideum indicates that the ubiquitin- and ATP-independent REGgamma proteasome is an ancient nuclear protease.
Masson P; Lundin D; Söderbom F; Young P
Eukaryot Cell; 2009 Jun; 8(6):844-51. PubMed ID: 19411624
[TBL] [Abstract][Full Text] [Related]
13. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
Schmidtke G; Kalveram B; Groettrup M
FEBS Lett; 2009 Feb; 583(3):591-4. PubMed ID: 19166848
[TBL] [Abstract][Full Text] [Related]
14. A SAGA of proteasomal ATPases.
Swaminathan S
Nat Cell Biol; 2006 Jan; 8(1):13. PubMed ID: 16389289
[No Abstract] [Full Text] [Related]
15. REGgamma, a proteasome activator and beyond?
Mao I; Liu J; Li X; Luo H
Cell Mol Life Sci; 2008 Dec; 65(24):3971-80. PubMed ID: 18679578
[TBL] [Abstract][Full Text] [Related]
16. E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells.
Mani A; Oh AS; Bowden ET; Lahusen T; Lorick KL; Weissman AM; Schlegel R; Wellstein A; Riegel AT
Cancer Res; 2006 Sep; 66(17):8680-6. PubMed ID: 16951183
[TBL] [Abstract][Full Text] [Related]
17. Mammalian 26S proteasomes remain intact during protein degradation.
Kriegenburg F; Seeger M; Saeki Y; Tanaka K; Lauridsen AM; Hartmann-Petersen R; Hendil KB
Cell; 2008 Oct; 135(2):355-65. PubMed ID: 18957208
[TBL] [Abstract][Full Text] [Related]
18. Role of the proteasome in ethanol-induced liver pathology.
Donohue TM; Cederbaum AI; French SW; Barve S; Gao B; Osna NA
Alcohol Clin Exp Res; 2007 Sep; 31(9):1446-59. PubMed ID: 17760783
[TBL] [Abstract][Full Text] [Related]
19. Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1.
Yi P; Feng Q; Amazit L; Lonard DM; Tsai SY; Tsai MJ; O'Malley BW
Mol Cell; 2008 Feb; 29(4):465-76. PubMed ID: 18313384
[TBL] [Abstract][Full Text] [Related]
20. 20S proteasomes and protein degradation "by default".
Asher G; Reuven N; Shaul Y
Bioessays; 2006 Aug; 28(8):844-9. PubMed ID: 16927316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
